/Investor DB

Harvard Management Company — 2021 Investments

7 investments dated 2021 · listed companies and verified rows first · show all

Evidently AIevidentlyai.comin𝕏Seed · Sep 2021

Evidently is an open-source library for monitoring machine learning models in production, offering 100+ built-in metrics for data quality, model drift detection, and performance tracking.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareLondon, GB

Elena Samuylova(Founder)inEmeli Dral(Founder)in

Co-investorsNauta CapitalRuna CapitalY CombinatorDavidovs Venture CollectiveDN CapitalFly Ventures+2 more

Moglixmoglix.comin𝕏May 2021 · $120M

Moglix is an Asia-based B2B e-commerce marketplace for procurement of industrial supplies, including MRO, safety, electricals, lighting, cleaning, office supplies, and power tools.

Advanced ManufacturingB2B MarketplacesE-commerceLogistics & Supply ChainSingapore, SG

Rahul Garg(Founder & CEO)inSandeep Goel(MD & COO)inAmit Kumar(MD & CBO)inSanjeev Arora(Chief Financial Officer)in

Co-investorsAccelJungle VenturesAlpha Wave GlobalNext Billion Capital PartnersPeak XV PartnersRocketship.vc+5 more

Poliglotapoliglota.orgin𝕏Seed · Mar 2021

Poliglota offers conversational language learning programs for English and other languages, combining group coaching sessions, practice clubs, and AI-powered practice through a method validated by Harvard research.

AI & Machine LearningEdTechSantiago, CL

Nicolas Fuenzalida(Founder)inCarlos Aravena(Founder)inJose Sanchez(Founder)inCarlos Vicente Aravena Espinoza(Executive Officer, Director)Bruno Vicenzi(COO)María José(Chief Human Resources Officer)

Co-investorsCapria VenturesInvexor Venture PartnersY CombinatorChileGlobal VenturesFen VenturesInvesto Capital+4 more

Promakhos Therapeuticspromakhos.comin𝕏Seed · Mar 2021

Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis.

BiotechHealthtechBoston, US

Katerina Chatzi(Founder)inJasper Edgar Neggers(Founder)inAIKATERINI CHATZI(Executive Officer, Director, Promoter)Katerina Chatzi, PhD(Founder)inKaterina Chatzi, Ph.D.(Co-founder, Chief Executive Officer and President)inJasper E. Neggers, Ph.D.(Co-Founder, Chief Scientific Officer and Secretary)

Co-investorsFoundersGaingelsMetaplanetPioneerY CombinatorZAKA VC+6 more

Queenlyqueenly.comin𝕏Seed · Jul 2021Defunct

Queenly is an online marketplace where users can buy and rent formal wear across iOS, Android, and web platforms.

ConsumerDirect to ConsumerE-commerceMarketplacesSan Francisco, US

Trisha Bantigue(Founder)inKathy Zhou-Patel(Founder)inTrisha Bantigue Tsao(Founder)inMengzhou Zhou(Director)Kathy Zhou(Founder)Dewandra Downs(Software Engineer)

Co-investorsAlumni VenturesAmino CapitalGaingelsInterlace VenturesRebel FundSHAKTI+14 more

Worksphereworksphere.comin𝕏Seed · Jan 2021Acquired

Worksphere provides a platform for companies to coordinate hybrid work arrangements, allowing employees to book desks and see colleague availability while helping organizations reduce real estate costs.

Enterprise SoftwareSaaSSeattle, US

Aakhil Fardeen(Founder)inTheresa Klaassen(Founder)inMark Piper(Founder)inAakhil Mohamed Fardeen(Executive Officer, Director, Promoter)Mark Wilson Piper(Director, Promoter)

Co-investorsAlumni VenturesAscend Venture CapitalSocii CapitalY CombinatorBasecamp FundJWass PT Investors+3 more

Zealthzealth-ai.cominSeed · Oct 2021

Zealth develops remote monitoring software that enables hospitals to track cancer patients after discharge and provide continuous automated support for managing treatment side effects and symptoms at home.

HealthtechBengaluru, IN

Monika Mehta(Founder)inDheeraj Mundhra(Founder)inCarl Byers(Director)Pranay Kapadia(Executive Officer, Director)Adam Ting(Executive Officer, Director)Justin White(Executive Officer, Director)

Co-investorsAntlerY CombinatorGoodwater CapitalICONIQ GrowthOak HC/FT

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.